News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
179,464 Results
Type
Article (17286)
Company Profile (126)
Press Release (162052)
Section
Business (58071)
Career Advice (929)
Deals (9326)
Drug Delivery (32)
Drug Development (23321)
Employer Resources (70)
FDA (2325)
Job Trends (4217)
News (91979)
Policy (5772)
Tag
Academia (481)
Alliances (16119)
Alzheimer's disease (376)
Antibody-drug conjugate (ADC) (50)
Approvals (2286)
Artificial intelligence (62)
Bankruptcy (79)
Best Places to Work (2860)
Biotechnology (117)
Breast cancer (46)
Cancer (439)
Career advice (749)
CAR-T (52)
Cell therapy (154)
Clinical research (18042)
Collaboration (207)
Compensation (36)
COVID-19 (727)
C-suite (68)
Data (392)
Diagnostics (1036)
Drug discovery (35)
Earnings (15567)
Employer resources (68)
Events (30551)
Executive appointments (170)
FDA (2449)
Funding (175)
Gene therapy (105)
GLP-1 (229)
Government (607)
Healthcare (2357)
Infectious disease (763)
Inflammatory bowel disease (55)
Interviews (135)
IPO (4045)
Job creations (1476)
Job search strategy (698)
Layoffs (132)
Legal (1172)
Lung cancer (54)
Manufacturing (90)
Medical device (676)
Medtech (677)
Mergers & acquisitions (5343)
Metabolic disorders (137)
Neuroscience (496)
NextGen Class of 2024 (1435)
Non-profit (448)
Northern California (540)
Obesity (75)
Opinion (164)
Patents (40)
People (21716)
Phase I (7015)
Phase II (8609)
Phase III (4858)
Pipeline (190)
Policy (38)
Postmarket research (301)
Preclinical (2872)
Press Release (61)
Radiopharmaceuticals (78)
Rare diseases (94)
Real estate (2433)
Recruiting (35)
Regulatory (4318)
Research institute (515)
Resumes & cover letters (151)
Series A (35)
Southern California (524)
Startups (1773)
United States (4590)
Vaccines (176)
Weight loss (64)
Date
Today (53)
Last 7 days (301)
Last 30 days (1388)
Last 365 days (12686)
2024 (11665)
2023 (13202)
2022 (16044)
2021 (16931)
2020 (13184)
2019 (9503)
2018 (7544)
2017 (8978)
2016 (8114)
2015 (9409)
2014 (9727)
2013 (9450)
2012 (6081)
2011 (6461)
2010 (5852)
Location
Africa (323)
Asia (13245)
Australia (2631)
California (1257)
Canada (457)
China (100)
Connecticut (46)
Europe (29602)
Florida (126)
Illinois (93)
Indiana (64)
Maryland (197)
Massachusetts (975)
Michigan (64)
Minnesota (91)
New Jersey (351)
New York (311)
North Carolina (252)
Northern California (540)
Ohio (41)
Pennsylvania (279)
South America (400)
Southern California (524)
Texas (129)
Washington State (228)
179,464 Results for "portage biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Portage Biotech Inc. reported that it has completed selling its equity holding in Intensity Therapeutics.
March 26, 2024
·
3 min read
Pharm Country
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives-Adenosine clinical development paused
Portage Biotech Inc. today reported that it is expanding its evaluation of strategic alternatives and implementing additional measures to extend its available cash runway.
April 12, 2024
·
3 min read
Drug Development
Portage Biotech Reports Business and Strategic Update
Portage Biotech Inc. today announced the outcome from the company’s comprehensive review of its pipeline in the context of the current capital raising market conditions.
January 4, 2024
·
4 min read
Press Releases
Portage Biotech Announces 1-for-20 Reverse Stock Split
August 13, 2024
·
4 min read
Business
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2024 and Business Update
August 27, 2024
·
9 min read
Business
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update
Portage Biotech Inc., a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, reported financial results for the fiscal quarter ended December 31, 2023.
February 28, 2024
·
12 min read
Press Releases
Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update
August 15, 2024
·
12 min read
Pharm Country
Portage Biotech Announces $6.0 Million Registered Direct Offering
Portage Biotech Inc. announced that it has entered into a definitive agreement for the purchase and sale in a registered direct offering of an aggregate of 3,157,895 shares of its common stock, at a purchase price of $1.90 per share.
September 29, 2023
·
6 min read
Business
Portage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagonists in Combination with KEYTRUDA® (Pembrolizumab) in Solid Tumors
Portage Biotech Inc. today announced that it has entered into a clinical trial collaboration agreement with Merck to evaluate Portage’s next-generation adenosine antagonists in combination with KEYTRUDA ® (pembrolizumab).
September 5, 2023
·
6 min read
Pharm Country
Portage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conference
Portage Biotech Inc. today announced that the Company’s management team will participate in a panel discussion at the Cantor Global Healthcare Conference on Thursday, September 28, 2023 at 10:20 – 10:50 AM ET in New York, NY.
September 20, 2023
·
1 min read
1 of 17,947
Next
